Travere Therapeutics (TVTX)

• Market cap: $3.55B
• 1 day: -1.59%
• 5 days: 14.87%
• 1 month: 9.32%
• 3 months: 56.68%
• 6 months: 162%
• Year to date: 108.96%
• 1 year: 122.95%
• 5 years: 44.41%
• 10 years: 103.18%
• Sector: Healthcare
• Industry: Biotechnology

About: Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

Employees: 385